电子健康记录中肾移植数据的通用性--Epic Cosmos 数据库与移植受者科学登记处的对比。

IF 8.9 2区 医学 Q1 SURGERY
Michal A Mankowski, Sunjae Bae, Alexandra T Strauss, Bonnie E Lonze, Babak J Orandi, Darren Stewart, Allan B Massie, Mara A McAdams-DeMarco, Eric K Oermann, Marlena Habal, Eduardo Iturrate, Sommer E Gentry, Dorry L Segev, David Axelrod
{"title":"电子健康记录中肾移植数据的通用性--Epic Cosmos 数据库与移植受者科学登记处的对比。","authors":"Michal A Mankowski, Sunjae Bae, Alexandra T Strauss, Bonnie E Lonze, Babak J Orandi, Darren Stewart, Allan B Massie, Mara A McAdams-DeMarco, Eric K Oermann, Marlena Habal, Eduardo Iturrate, Sommer E Gentry, Dorry L Segev, David Axelrod","doi":"10.1016/j.ajt.2024.11.008","DOIUrl":null,"url":null,"abstract":"<p><p>Developing real-world evidence from electronic health records (EHR) is vital to advance kidney transplantation (KT). We assessed the feasibility of studying KT using the Epic Cosmos aggregated EHR dataset, which includes 274 million unique individuals cared for in 238 U.S. health systems, by comparing it with the Scientific Registry of Transplant Recipients (SRTR). We identified 69,418 KT recipients transplanted between January 2014 and December 2022 in Cosmos (39.4% of all US KT transplants during this period). Demographics and clinical characteristics of recipients captured in Cosmos were consistent with the overall SRTR cohort. Survival estimates were generally comparable, although there were some differences in long-term survival. At 7 years post-transplant, patient survival was 80.4% in Cosmos and 77.8% in SRTR. Multivariable Cox regression showed consistent associations between clinical factors and mortality in both cohorts, with minor discrepancies in the associations between death and both age and race. In summary, Cosmos provides a reliable platform for KT research, allowing EHR-level clinical granularity not available with either the transplant registry or healthcare claims. Consequently, Cosmos will enable novel analyses to improve our understanding of KT management on a national scale.</p>","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":" ","pages":""},"PeriodicalIF":8.9000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Generalizability of Kidney Transplant Data in Electronic Health Records - The Epic Cosmos Database versus the Scientific Registry of Transplant Recipients.\",\"authors\":\"Michal A Mankowski, Sunjae Bae, Alexandra T Strauss, Bonnie E Lonze, Babak J Orandi, Darren Stewart, Allan B Massie, Mara A McAdams-DeMarco, Eric K Oermann, Marlena Habal, Eduardo Iturrate, Sommer E Gentry, Dorry L Segev, David Axelrod\",\"doi\":\"10.1016/j.ajt.2024.11.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Developing real-world evidence from electronic health records (EHR) is vital to advance kidney transplantation (KT). We assessed the feasibility of studying KT using the Epic Cosmos aggregated EHR dataset, which includes 274 million unique individuals cared for in 238 U.S. health systems, by comparing it with the Scientific Registry of Transplant Recipients (SRTR). We identified 69,418 KT recipients transplanted between January 2014 and December 2022 in Cosmos (39.4% of all US KT transplants during this period). Demographics and clinical characteristics of recipients captured in Cosmos were consistent with the overall SRTR cohort. Survival estimates were generally comparable, although there were some differences in long-term survival. At 7 years post-transplant, patient survival was 80.4% in Cosmos and 77.8% in SRTR. Multivariable Cox regression showed consistent associations between clinical factors and mortality in both cohorts, with minor discrepancies in the associations between death and both age and race. In summary, Cosmos provides a reliable platform for KT research, allowing EHR-level clinical granularity not available with either the transplant registry or healthcare claims. Consequently, Cosmos will enable novel analyses to improve our understanding of KT management on a national scale.</p>\",\"PeriodicalId\":123,\"journal\":{\"name\":\"American Journal of Transplantation\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":8.9000,\"publicationDate\":\"2024-11-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Transplantation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ajt.2024.11.008\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajt.2024.11.008","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

摘要

从电子健康记录(EHR)中获取真实世界的证据对于推进肾移植(KT)至关重要。我们评估了使用 Epic Cosmos 聚合电子病历数据集研究肾移植的可行性,该数据集包括美国 238 个医疗系统护理的 2.74 亿名患者,我们将其与肾移植受者科学注册表 (SRTR) 进行了比较。我们在 Cosmos 中确定了 2014 年 1 月至 2022 年 12 月期间移植的 69418 例 KT 受者(占同期美国 KT 移植总数的 39.4%)。Cosmos 采集到的受者的人口统计学和临床特征与 SRTR 整体队列一致。尽管长期存活率存在一些差异,但存活率估计值基本相当。移植后 7 年的存活率,Cosmos 为 80.4%,SRTR 为 77.8%。多变量考克斯回归显示,两个队列的临床因素与死亡率之间存在一致的关联,死亡与年龄和种族之间的关联略有差异。总之,Cosmos 为 KT 研究提供了一个可靠的平台,可实现 EHR 级别的临床粒度,这是移植登记或医疗索赔所不具备的。因此,Cosmos 可以进行新颖的分析,以提高我们对全国范围内 KT 管理的了解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Generalizability of Kidney Transplant Data in Electronic Health Records - The Epic Cosmos Database versus the Scientific Registry of Transplant Recipients.

Developing real-world evidence from electronic health records (EHR) is vital to advance kidney transplantation (KT). We assessed the feasibility of studying KT using the Epic Cosmos aggregated EHR dataset, which includes 274 million unique individuals cared for in 238 U.S. health systems, by comparing it with the Scientific Registry of Transplant Recipients (SRTR). We identified 69,418 KT recipients transplanted between January 2014 and December 2022 in Cosmos (39.4% of all US KT transplants during this period). Demographics and clinical characteristics of recipients captured in Cosmos were consistent with the overall SRTR cohort. Survival estimates were generally comparable, although there were some differences in long-term survival. At 7 years post-transplant, patient survival was 80.4% in Cosmos and 77.8% in SRTR. Multivariable Cox regression showed consistent associations between clinical factors and mortality in both cohorts, with minor discrepancies in the associations between death and both age and race. In summary, Cosmos provides a reliable platform for KT research, allowing EHR-level clinical granularity not available with either the transplant registry or healthcare claims. Consequently, Cosmos will enable novel analyses to improve our understanding of KT management on a national scale.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
18.70
自引率
4.50%
发文量
346
审稿时长
26 days
期刊介绍: The American Journal of Transplantation is a leading journal in the field of transplantation. It serves as a forum for debate and reassessment, an agent of change, and a major platform for promoting understanding, improving results, and advancing science. Published monthly, it provides an essential resource for researchers and clinicians worldwide. The journal publishes original articles, case reports, invited reviews, letters to the editor, critical reviews, news features, consensus documents, and guidelines over 12 issues a year. It covers all major subject areas in transplantation, including thoracic (heart, lung), abdominal (kidney, liver, pancreas, islets), tissue and stem cell transplantation, organ and tissue donation and preservation, tissue injury, repair, inflammation, and aging, histocompatibility, drugs and pharmacology, graft survival, and prevention of graft dysfunction and failure. It also explores ethical and social issues in the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信